Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Norepinephrine Bitartrate Injection

Approval Number

国药准字H20247024

Company上海禾丰制药有限公司

Registration Date

February 5, 2024

Previous Approval Numbers

国药准字H31021177

Drug Information

Generic Name

重酒石酸去甲肾上腺素注射液

Dosage Form

注射剂

Strength

4ml:8mg

Drug Type

化学药品

Registration Date

February 5, 2024

Company Information

Applicant Company

Company Name上海禾丰制药有限公司

Company Address

中国（上海）自由贸易试验区金沪路805号

Manufacturing Company

Company Name上海禾丰制药有限公司

Company Address

中国（上海）自由贸易试验区金沪路805号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy